Compare RNA & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNA | LTRX |
|---|---|---|
| Founded | 2012 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.5M | 236.4M |
| IPO Year | 2025 | 2000 |
| Metric | RNA | LTRX |
|---|---|---|
| Price | $14.01 | $5.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 3 |
| Target Price | ★ $69.26 | $6.50 |
| AVG Volume (30 Days) | 127.7K | ★ 729.9K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $122,923,000.00 |
| Revenue This Year | $88.12 | $1.12 |
| Revenue Next Year | $18.11 | $15.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.13 | $4.37 |
| 52 Week High | $73.06 | $8.75 |
| Indicator | RNA | LTRX |
|---|---|---|
| Relative Strength Index (RSI) | 66.94 | 52.43 |
| Support Level | $12.72 | $5.88 |
| Resistance Level | $14.05 | $6.09 |
| Average True Range (ATR) | 0.51 | 0.41 |
| MACD | 0.17 | -0.03 |
| Stochastic Oscillator | 94.17 | 33.33 |
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.